<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE345nnn/GSE345888/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Other</omics_type><species>Homo sapiens</species><gds_type>Other</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE345888</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion -- Submission 1 of 2 (Bulk TCR)</name><description>Allogeneic CAR T cells could overcome limitations of autologous therapies but are limited by immune rejection. We evaluated 11 patients with large B-cell lymphoma treated with a single lot of cemacabtagene ansegedleucel (cema-cel), an allogeneic anti-CD19 CAR T product. Despite receiving identical infusion products, patients exhibited heterogeneous cema-cel expansion and clinical outcomes. Our integrated analyses using longitudinal TCRβ sequencing, single-cell molecular profiling, and mixed lymphocyte reaction assays revealed that high frequencies of pre-existing, recipient-derived alloreactive CD8+ T cells mediated rapid CAR T rejection in non-expanders. Furthermore, effector-like features, rather than stem/central memory programs, drove robust clonal CAR T expansion consistently across expanders. We confirmed similar expansion patterns in two independent cohorts treated with a separate lot of cema-cel or an allogeneic anti-BCMA CAR T product. These findings highlight distinct cell-extrinsic and cell-intrinsic mechanisms that influence allogeneic CAR T performance and provide insights to optimize donor selection, manufacturing, and product design.</description><dates><publication>2026/09/23</publication></dates><accession>GSE345888</accession><cross_references><GSM>GSM10018568</GSM><GSM>GSM10018601</GSM><GSM>GSM10018569</GSM><GSM>GSM10018602</GSM><GSM>GSM10018575</GSM><GSM>GSM10018576</GSM><GSM>GSM10018577</GSM><GSM>GSM10018578</GSM><GSM>GSM10018571</GSM><GSM>GSM10018572</GSM><GSM>GSM10018573</GSM><GSM>GSM10018574</GSM><GSM>GSM10018570</GSM><GSM>GSM10018539</GSM><GSM>GSM10018579</GSM><GSM>GSM10018537</GSM><GSM>GSM10018538</GSM><GSM>GSM10018586</GSM><GSM>GSM10018542</GSM><GSM>GSM10018543</GSM><GSM>GSM10018587</GSM><GSM>GSM10018588</GSM><GSM>GSM10018544</GSM><GSM>GSM10018589</GSM><GSM>GSM10018545</GSM><GSM>GSM10018582</GSM><GSM>GSM10018583</GSM><GSM>GSM10018540</GSM><GSM>GSM10018584</GSM><GSM>GSM10018585</GSM><GSM>GSM10018541</GSM><GSM>GSM10018580</GSM><GSM>GSM10018581</GSM><GSM>GSM10018546</GSM><GSM>GSM10018547</GSM><GSM>GSM10018548</GSM><GSM>GSM10018549</GSM><GSM>GSM10018597</GSM><GSM>GSM10018553</GSM><GSM>GSM10018554</GSM><GSM>GSM10018598</GSM><GSM>GSM10018599</GSM><GSM>GSM10018555</GSM><GSM>GSM10018556</GSM><GSM>GSM10018593</GSM><GSM>GSM10018594</GSM><GSM>GSM10018550</GSM><GSM>GSM10018551</GSM><GSM>GSM10018595</GSM><GSM>GSM10018596</GSM><GSM>GSM10018552</GSM><GSM>GSM10018590</GSM><GSM>GSM10018591</GSM><GSM>GSM10018592</GSM><GSM>GSM10018557</GSM><GSM>GSM10018558</GSM><GSM>GSM10018559</GSM><GSM>GSM10018564</GSM><GSM>GSM10018565</GSM><GSM>GSM10018566</GSM><GSM>GSM10018600</GSM><GSM>GSM10018567</GSM><GSM>GSM10018560</GSM><GSM>GSM10018561</GSM><GSM>GSM10018562</GSM><GSM>GSM10018563</GSM><GPL>30173</GPL><GPL>24676</GPL><GSE>345888</GSE><taxon>Homo sapiens</taxon><PMID>[42788887]</PMID></cross_references></HashMap>